Cargando…

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis()

The efficacy of Bacillus Calmette-Guerin (BCG) vaccination in protection against pulmonary tuberculosis (TB) is highly variable between populations. One possible explanation for this variability is increased exposure of certain populations to non-tuberculous mycobacteria (NTM). This study used a mur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poyntz, Hazel C., Stylianou, Elena, Griffiths, Kristin L., Marsay, Leanne, Checkley, Anna M., McShane, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Churchill Livingstone 2014
Materias:	Immunological Aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066954/ https://www.ncbi.nlm.nih.gov/pubmed/24572168 http://dx.doi.org/10.1016/j.tube.2013.12.006

Ejemplares similares

Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice
por: Griffiths, Kristin L., et al.
Publicado: (2013)

Genetic diversity of Mycobacterium tuberculosis isolated from tuberculosis patients in the Serengeti ecosystem in Tanzania
por: Mbugi, Erasto V., et al.
Publicado: (2015)

Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
por: Minassian, Angela M., et al.
Publicado: (2011)

Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination
por: Harris, Stephanie A., et al.
Publicado: (2014)

Cobalamin is present in cells of non-tuberculous mycobacteria, but not in Mycobacterium tuberculosis
por: Minias, Alina, et al.
Publicado: (2021)

Identification of Antigens Specific to Non-Tuberculous Mycobacteria: The Mce Family of Proteins as a Target of T Cell Immune Responses
por: Checkley, Anna M., et al.
Publicado: (2011)

Mycobacterium tuberculosis-specific plasmablast levels are differentially modulated in tuberculosis infection and disease
por: Gindeh, Awa, et al.
Publicado: (2020)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
por: Stylianou, E., et al.
Publicado: (2015)

Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions
por: Verma, Deepshikha, et al.
Publicado: (2020)

Individual Mycobacterium tuberculosis universal stress protein homologues are dispensable in vitro
por: Hingley-Wilson, S.M., et al.
Publicado: (2010)

Metabolic activity of mature biofilms of Mycobacterium tuberculosis and other non-tuberculous mycobacteria
por: Solokhina, Anna, et al.
Publicado: (2017)

Differential Responses by Human Macrophages to Infection With Mycobacterium tuberculosis and Non-tuberculous Mycobacteria
por: Feng, Zhihong, et al.
Publicado: (2020)

Antimycobacterial Activity of Hedeoma drummondii against Mycobacterium tuberculosis and Non-Tuberculous Mycobacteria
por: Molina-Torres, Carmen, et al.
Publicado: (2023)

Pathways of IL-1β secretion by macrophages infected with clinical Mycobacterium tuberculosis strains()
por: Krishnan, Nitya, et al.
Publicado: (2013)

Characterisation of the Mycobacterium tuberculosis alternative sigma factor SigG: Its operon and regulon()
por: Gaudion, Alison, et al.
Publicado: (2013)

Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis
por: Mzinza, David T., et al.
Publicado: (2015)

The Tuberculin Skin Test (TST) Is Affected by Recent BCG Vaccination but Not by Exposure to Non-Tuberculosis Mycobacteria (NTM) during Early Life
por: Burl, Sarah, et al.
Publicado: (2010)

Enhanced expression of recX in Mycobacterium tuberculosis owing to a promoter internal to recA
por: Forse, Lorna N., et al.
Publicado: (2011)

Mycobacterium tuberculosis WhiB1 represses transcription of the essential chaperonin GroEL2
por: Stapleton, Melanie R., et al.
Publicado: (2012)

Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection
por: Betts, Gareth, et al.
Publicado: (2012)

Mycobacteria-Specific T Cells Are Generated in the Lung During Mucosal BCG Immunization or Infection With Mycobacterium tuberculosis
por: Basile, Juan I., et al.
Publicado: (2020)

The Mycobacterium tuberculosis β-oxidation genes echA5 and fadB3 are dispensable for growth in vitro and in vivo
por: Williams, Kerstin J., et al.
Publicado: (2011)

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining
por: Smith, Steven G, et al.
Publicado: (2010)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
por: Satti, Iman, et al.
Publicado: (2022)

Role of GenoType(®) Mycobacterium Common Mycobacteria/Additional Species Assay for Rapid Differentiation Between Mycobacterium tuberculosis Complex and Different Species of Non-Tuberculous Mycobacteria
por: Singh, Amresh Kumar, et al.
Publicado: (2013)

Editorial Commentary: Understanding BCG Is the Key to Improving It
por: McShane, Helen
Publicado: (2014)

Isolation of Non-Tuberculous Mycobacteria in Children Investigated for Pulmonary Tuberculosis
por: Hatherill, Mark, et al.
Publicado: (2006)

Mycobacterium szulgai: A Rare Cause of Non-Tuberculous Mycobacteria Disseminated Infection
por: Nunes, Ana Luisa, et al.
Publicado: (2022)

Evaluation of an immunochromatographic test for discrimination between Mycobacterium tuberculosis complex & non tuberculous mycobacteria in clinical isolates from extra-pulmonary tuberculosis
por: Maurya, Anand Kumar, et al.
Publicado: (2012)

Validation of Biomarkers for Distinguishing Mycobacterium tuberculosis from Non-Tuberculous Mycobacteria Using Gas Chromatography−Mass Spectrometry and Chemometrics
por: Dang, Ngoc A., et al.
Publicado: (2013)

Editorial: Genomics-based strategies for advanced drug resistance and epidemiological surveillance of Mycobacterium tuberculosis and other non-tuberculous mycobacteria
por: Ghodousi, Arash, et al.
Publicado: (2023)

Local Pulmonary Immunological Biomarkers in Tuberculosis
por: Morrison, Hazel, et al.
Publicado: (2021)

Editorial: Tuberculosis and Non-tuberculous Mycobacteria Infections: Control, Diagnosis and Treatment
por: Opota, Onya, et al.
Publicado: (2021)

Why don’t we have an effective tuberculosis vaccine yet?
por: Davenne, Tamara, et al.
Publicado: (2016)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis
por: Zelmer, Andrea, et al.
Publicado: (2016)

Protective Efficacy of BCG Vaccine against Mycobacterium leprae and Non-Tuberculous Mycobacterial Infections
por: Orujyan, Davit, et al.
Publicado: (2022)

Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis
por: Matthews, Kerryn, et al.
Publicado: (2011)

The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019)

Differential detection of tuberculous and non-tuberculous mycobacteria by qPCR in lavage fluids of tuberculosis-suspicious white rhinoceros
por: Hermes, Robert, et al.
Publicado: (2018)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery()
por: Meyer, Joel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0g77j7mejfr6k9b8aat6uuo3ai